凝血標(biāo)志物在危重癥血栓性疾病患者診斷中的應(yīng)用及與炎性因子的相關(guān)性研究
發(fā)布時間:2018-11-19 10:24
【摘要】:目的:評價危重癥血栓性疾病患者的凝血標(biāo)志物的變化,分析其與炎性因子的相關(guān)性,探討凝血標(biāo)志物對危重癥患者靜脈血栓形成的診斷意義。方法:檢測38例危重癥血栓性疾病患者(血栓組)和81例疾病未發(fā)生血栓的患者(對照組)的凝血標(biāo)志物血栓調(diào)節(jié)蛋白(TM)、凝血酶-抗凝血酶Ⅲ復(fù)合物(TAT)、纖溶酶-α2纖溶酶抑制劑復(fù)合物(PIC)、組織型纖溶酶原激活劑-抑制劑1復(fù)合物(t-PAIC)、D二聚體(D-Dimer)、纖維蛋白原溶解產(chǎn)物(FDP)和炎性因子降鈣素原(PCT)、C反應(yīng)蛋白(CRP)以及白介素-6(IL-6)的水平,分析其變化及相關(guān)性。結(jié)果:血栓性疾病組凝血標(biāo)志物TM、TAT、PIC、D-D和FDP水平高于對照組,差異具有統(tǒng)計學(xué)意義(P0.05);而t-PAIC水平差異無統(tǒng)計學(xué)意義(P0.05)。血栓性疾病組炎性因子PCT、CRP和IL-6水平高于對照組,差異具有統(tǒng)計學(xué)意義(P0.05)。相關(guān)性分析顯示,凝血標(biāo)志物TM與炎性因子PCT、CRP、IL-6的相關(guān)系數(shù)分別為0.288,0.249,0.270(P0.05)。結(jié)論:危重癥血栓性疾病患者存在有凝血和纖溶系統(tǒng)的活化,同時伴有全身炎癥反應(yīng)水平明顯增高。炎癥反應(yīng)與血栓形成之間存在網(wǎng)絡(luò)關(guān)系,凝血因子和炎性因子相互作用共同發(fā)揮促凝和促炎作用。
[Abstract]:Objective: to evaluate the changes of coagulation markers in critically ill patients with thrombotic diseases, to analyze the correlation between coagulation markers and inflammatory factors, and to explore the diagnostic significance of coagulation markers for venous thrombosis in critically ill patients. Methods: thrombomodulin (TM), thrombin 鈪,
本文編號:2342017
[Abstract]:Objective: to evaluate the changes of coagulation markers in critically ill patients with thrombotic diseases, to analyze the correlation between coagulation markers and inflammatory factors, and to explore the diagnostic significance of coagulation markers for venous thrombosis in critically ill patients. Methods: thrombomodulin (TM), thrombin 鈪,
本文編號:2342017
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2342017.html
最近更新
教材專著